We are live on ! Find out more
ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of ACHN yet.

ACHN Hedge Fund Activity: Q1 2020 in Review

0 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q1 2020, worth a combined $0 — down 100% from $755M a quarter earlier.

Sellers outnumbered buyers: 129 funds closed out of ACHN and 0 opened new positions — a net loss of 129 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $79M sold.

  • 0 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q1 2020, down from 132 in Q4 2019.
  • Funds reported $0 of Achillion Pharmaceuticals stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Achillion Pharmaceuticals positions in Q1 2020 and 129 closed out, a net change of -129 holders.
  • The largest Achillion Pharmaceuticals seller in Q1 2020 was Vanguard Group, an estimated $79M sold.

Based on aggregated 13F filings for Q1 2020.